High-Purity (S)-(+)-2-Chlorophenylglycine Methyl Ester Tartrate: A Key Pharmaceutical Intermediate

Discover the critical role of (S)-(+)-2-Chlorophenylglycine methyl ester tartrate in advanced pharmaceutical synthesis. As a leading manufacturer and supplier, we provide high-quality chiral intermediates essential for producing vital medications like clopidogrel. Secure your supply chain with our reliable products and competitive pricing.

Get a Quote & Sample

Advantages of Sourcing Our Chiral Pharmaceutical Intermediates

Exceptional Purity and Enantiomeric Excess

Our (S)-(+)-2-Chlorophenylglycine methyl ester tartrate consistently achieves high enantiomeric excess, crucial for the targeted therapeutic effects of drugs like clopidogrel. Rely on our meticulous quality control processes.

Advanced Synthesis & Cost-Effectiveness

We utilize innovative methods such as attrition-enhanced deracemization to provide high yields and purity, offering a cost-effective solution for bulk procurement of chiral intermediates.

Reliable Global Supply Chain

As a prominent manufacturer and exporter, we ensure consistent availability and timely delivery, supporting the stability of your R&D and production pipelines. Find the best price from our factory.

Key Applications in Pharmaceutical Development

Clopidogrel Synthesis

Serves as a pivotal chiral intermediate in the industrial synthesis of clopidogrel, a widely prescribed antiplatelet medication. Its stereochemical integrity is paramount for drug efficacy.

Chiral Building Block

Acts as a versatile chiral building block for the synthesis of other complex biologically active molecules and APIs, offering flexibility in medicinal chemistry research.

API Intermediate Manufacturing

Essential for pharmaceutical companies and contract manufacturers engaged in the large-scale production of active pharmaceutical ingredients, ensuring quality and compliance.

Research and Development

Valuable for R&D scientists studying chiral recognition, stereoselective synthesis, and exploring new drug candidates that require precise stereochemistry.